Clopiside ASP Capsule is a dual antiplatelet medication that combines Clopidogrel (75 mg) and Aspirin (75 mg) to help prevent blood clot formation in individuals at risk of cardiovascular diseases. It is widely prescribed to reduce the chances of heart attacks, strokes, and other clot-related complications, especially in patients with coronary artery disease (CAD), peripheral artery disease (PAD), or those who have undergone angioplasty or stent placement.
Clopidogrel, a P2Y12 inhibitor, works by preventing platelets from sticking together, thereby reducing the risk of clot formation in arteries. Aspirin, an NSAID and antiplatelet agent, further enhances this effect by inhibiting thromboxane A2 production, preventing platelets from clustering and forming harmful clots.
This combination is commonly used in dual antiplatelet therapy (DAPT) to provide comprehensive cardiovascular protection. It helps in maintaining smooth blood flow and prevents blockages that could lead to life-threatening events like myocardial infarction (heart attack) or ischemic stroke. Regular use of Clopidile A75 under medical supervision is essential for patients who have undergone stenting, bypass surgery, or other cardiac procedures.